1. C. F. Lucchinetti and R. Hohlfeld, Multiple Sclerosis 3, in: Blue Books of Neurology Series, Saunders (2010), Vol. 35, No. 6, pp. 122–124.
2. A. N. Boiko, N. F. Smirnova, S. N. Zolotova, and E. I. Gusev, “Epidemiology and etiology of multiple sclerosis,” Consilium Medicum., 10, No. 7, 5–8 (2008).
3. M. Freedman, E. Thompson, F. Deisenhammer, et al., “Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis,” Arch Neurol., 62, No. 6 (2005), doi:
10.1001/archneur.62.6.865
.
4. S. V. Lapin and E. P. Evdoshenko, “Laboratory methods for the diagnosis of multiple sclerosis and other neurological diseases,” in: Handbook of Main Clinical Diagnostic Laboratories, No. 1, 22–32 (2011).
5. E. Meinl, M. Krumbholz, and R. B. Hohlfeld, “B lineage cells in the inflammatory central nervous system environment: Migration, main tenance, local antibody production, and therapeutic modulation,” Ann. Neurol., 59, No. 6, 880–892 (2006), doi:
10.1002/ana.20890
.